Member Info for ForFXSake

Nor Joanne. That is a good sign, I suppose but will it be enough to protect us from vultures, if there are any out there?

I expected there to be some price volatility in the run up to the end of Q1. Could be down to MM's/brokers or could be down to other activity.

I'm holding firm in the hope that the company silence is an indication that more is to come very soon on NXP002 front. They need to close this wretched Asian deal saga once and for all or strike something new with someone else. If they don't add value soon then who knows what will happen in the next few months.

If Ebers are moving forward and NFX is struggling then it wouldn't surprise me to see a derisory offer to take us out, just to acquire whatever knowhow/IP is relevant to them.

I'm hoping that the new team is not caught like a rabbit in the headlights and have a firm plan to turn this around without sh*fting the long suffering PI's.

Definitely starting to feel like someone's playing games.

We're counting on your intuition Bob.

It's been a week now since the news about the NXP002 results and no-one from the company has stepped forward to big it up in social media or anywhere.

That's either a very good sign or a very bad sign. I'm hoping its the former.

Yes DJH, they're just hypothetical musings.

Can you imagine though, if somebody was working to that goal, they might tempted to offload alot of their own holding in order to rock the boat and unsettle the confidence of other investors. I mean, they'd get everything back if they succeeded. It would certainly help to make things uncomfortable for any new team trying to get things back on track. Cause more stress and pressure.

However, if I was doing something like that then I would be feeling very exposed right about now. If Anne and team did deliver something in Q1 and things started to recover then it would all have been sacrificed for nothing.

I can't see anybody being that stupid, so its just a silly thought.

As an aside, I seem to remember a rather large number of votes being raised against the re-election of Keegan and Blackwell at the AGM last year. I thought it odd at the time given that they were the ones we were all counting on to steer us through the mess that had been created.

I wonder who that was and what their rationale was too? It seems senseless on the face of it. What would they have achieved if they had been successful? Would the company have failed and gone into administration? How would those shareholders have benefitted? Wouldn't they lose everything too?

The only way I could imagine such an influential group of shareholders actually benefitting from the company going into administration is if they were well placed enough to salvage the parts they wanted on the cheap and take it private again. I suppose you could make it all back and much more.

Anyway, sorry to go off topic. Not sure why I thought of that.

Good luck Anne and team!

I just hope that any rise they eventually sell into has so much force that it leaves them with a severe sense of regret for dumping what they have already.

They're like a double act, offloading at the same time.

Can't you try planting some of them in your allotment, see if you can't get them growing?

:0)

We've not had a single Buy related TR-1 over the last year so who is soaking up all the sells? Is it the retailers or are the MMs holding more than they normally would in anticipation of news?

OSS, yes I get your point.

The 2018 tests for NXP002 alone vs IPF were multi donor and therefore carry weight. I think it is still valid to say that the current test to prove that NXP002 is complimentary to current SOC is a different test in that it was intended to prove that it is still beneficial when offered alongside current SOC. My point was that a multi donor test here (if possible) would have removed any doubts that could be raised about it being a fluke result.

I accept that the boundaries of this test may have been agreed upfront between relevant parties and may be enough to move forward. We shall see in good time how that pans out.

I take both of their points on too Jiving. I want to see this succeed as much as anyone else but we've had some pretty poor management and feel like asking questions as I'm sick of watching my hard-earned get p*ssed away for little progress other than to justify more fundraising just to keep the lights on.

I'm not sure what the true figures are for UK IPF deaths but I got a rough figure of 5.5k and rising from this website:

https://pulmonaryfibrosisnews.com/2019/08/05/mortality-rate-due-to-ipf-has-risen-in-united-kingdom-data-show/

I would have hoped that there would be enough donors from a number of that size that would be willing to help combat this disease for the future but I don't really appreciate the complexities or know the true figures so will not argue any further about the single donor test point. I just know that releasing data from donor does not look as convincing as it would from several.

If OSS is correct about this test being for interested western 3rd parties then it was probably designed and agreed that way and your point about Roche and BI being interested may be closer to the truth than I thought, who knows? To be honest, I think I would rather see a deal done with a fresh and eager new partner than a company that has been dragging its heels for the last 18 months.

Jiving, your point is very valid. However, has the same logic not also applied to our Asian 'partners' over the last 18 months as well? Why have they not jumped in yet?

Although I think this is good news and a step forward, I am slightly confused as to why they didn't test this on the tissue from multiple donors, even if it was just several. Surely that would have strengthened the data many times over.

My point is, is this data strong enough on its own to strike deals with? If so, then surely the 'partner' we have been talking to for the last 18 months must be chomping at the bit. Why would they delay further and leave the opportunity for someone else to beat them to it?

If the data is not strong enough then what is the point of releasing it? Is it just to qualify for the Innovate grant? Then what? The Innovate grant is unlikely to be enough to develop in-house and if we haven't got enough data to encourage a partner then the only other option is a fundraiser to enable them to take it forward themselves.

Now we haven't had the usual Proactive interview to big up the RNS yet. I'm hoping that is because Anne is currently finalising details of the legendary deal with our eager Asian parties rather than just waiting for the nice people from Innovate to give her a call.

If the Asian partners are still not biting then I think shareholders deserve to know why.

We shall see.

Let's just hope yesterday's results aren't just being used to appease an angry investor mob, like the last NXP004 results were (following which we've seen zilch progress on)

Don't forget to post your TR-1 Bob. You must be getting near now!

There is so much going on here that it would surely take an extreme level of incompetence to not be able to deliver anything at all.

I agree entirely with you that they cannot afford to change direction.

Not sure that will be the case though. Especially without a deal. Time will tell

*can't

It can hurt to have an Anne with a plan